Marco Maria Germani
University of Pisa(IT)Azienda Ospedaliera Universitaria Pisana(IT)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Human Pathophysiological Adaptations to the Space Environment(2017)334 cited
- → RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer(2022)107 cited
- → Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications(2021)75 cited
- → Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge(2020)58 cited
- → Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability(2022)58 cited
- → Tumour mutational burden as a biomarker in patients with mismatch repair deficient/microsatellite instability-high metastatic colorectal cancer treated with immune checkpoint inhibitors(2023)52 cited
- → The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation Oncologists(2024)46 cited
- → EGFRAmplification in Metastatic Colorectal Cancer(2021)33 cited
- → Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials(2020)29 cited
- → Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy(2022)28 cited